The global need for effective antibiotics - Moving towards concerted action

Drug Resistance Updates

Volumn 14, Issue 2, 2011, Pages 68-69

  Cars, Otto ^a   Hedin, Anna ^a   Heddini, Andreas ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Antibacterial; Antibiotic resistance; Bacterial infections; Clinical trials; Drug discovery; Drug regulation; Emerging infectious diseases; Globalization; Health systems; Innovation; Microbiology; Pharmacology; Rational use of drugs; Surveillance

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; CONFERENCE PAPER; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE SYSTEM; HUMAN; MEDICAL TECHNOLOGY; PRIORITY JOURNAL; PUBLIC HEALTH;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; DRUG AND NARCOTIC CONTROL; DRUG DISCOVERY; DRUG RESISTANCE, BACTERIAL; HUMANS; INTERNATIONAL COOPERATION; PANDEMICS;

EID: 79955752612     PISSN: 13687646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drup.2011.02.006     Document Type: Conference Paper

References (9)

1. B. Bergström The role of the pharmaceutical industry in meeting the public health threat of antibacterial resistance Drug Resist. Updates 14 2011 77 78
2. B. Blomberg, K.P. Manji, W.K. Urassa, B.S. Tamim, D.S. Mwakagile, R. Jureen, V. Msangi, M.G. Tellevik, M. Holberg-Petersen, S. Harthug, S.Y. Maselle, and N. Langeland Antimicrobial resistance predicts death in Tanzanian children with bloodstream infections: a prospective cohort study BMC Infect. Dis. 7 2007 43
3. ECDC/EMEA, 2009. ECDC/EMEA Joint Technical Report: The bacterial challenge: time to react. Stockholm, Sweden. http://www.ecdc.europa.eu/en/ publications/Publications/Forms/ECDC-DispForm.aspx?ID=444.
4. J. Fernebro Fighting Bacterial Infections - Future Treatment Options Drug Resist. Updates 14 2011 125 139
5. L. Freire-Moran, B. Aronsson, C. Manz, I.C. Gyssens, A.D. So, D.L. Monnet, O. Cars ECDC-EMA Working Group Critical shortage of new antibiotics in development against multidrug-resistant bacteria - time to react is now! Drug Resist Updates 14 2011 118 124
6. H. Grundmann, D.L. Monnet, K. Klugman, T. Walsh, J. Stelling, P. Ramon-Pardo, B. Sigauque, W. Khan, R. Laxminarayan, and A. Heddini Developing framework for priority settings for new antibiotics Drug Resist. Update 14 2011 79 87
7. J.W. Mouton, P. Ambrose, R. Canton, G. Drusano, S. Harbarth, A. Macgowan, U. Theuretzbacher, and J. Turnidge Conserving Antibiotics for the future: new ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective Drug Resist. Updates 14 2011 107 117
8. I.N. Okeke, R.W. Peeling, H. Goossens, R. Auckenthaler, S.S. Olmsted, J. de Lavison, B.L. Zimmer, M.D. Perkins, and K. Nordqvist Diagnostics as essential tools for containing antibacterial resistance Drug Resist. Updates 14 2011 95 106
9. A.D. So, N. Gupta, S.K. Bramachari, I. Chopra, B. Munos, K. Outterson, J.P. Paccaud, D.J. Payne, R.W. Peeling, M. Spigelman, and J. Weigelt Towards new business models for research and development for novel antibiotics Drug Resist. Updates 14 2011 88 94